Larsen & Toubro Limited (LON:LTOD)
22.20
+0.10 (0.45%)
Jul 22, 2022, 8:01 AM BST
Larsen & Toubro Revenue
Larsen & Toubro had revenue of 650.36B INR in the quarter ending June 30, 2025, with 16.05% growth. This brings the company's revenue in the last twelve months to 2.69T, up 15.76% year-over-year. In the fiscal year ending March 31, 2025, Larsen & Toubro had annual revenue of 2.60T with 15.37% growth.
Revenue (ttm)
2.69T INR
Revenue Growth
+15.76%
P/S Ratio
2.02
Revenue / Employee
49.23M INR
Employees
54,596
Market Cap
46.20B GBP
Revenue Chart
* This company reports financials in INR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.60T | 346.17B | 15.37% |
| Mar 31, 2024 | 2.25T | 389.95B | 20.94% |
| Mar 31, 2023 | 1.86T | 274.43B | 17.29% |
| Mar 31, 2022 | 1.59T | 194.24B | 13.94% |
| Mar 31, 2021 | 1.39T | -85.00B | -5.75% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |